CD8A and neoplasm: Following treatment, the frequency of these Tfh cells tended to decrease, probably due to their homing to tumor microenvironment where Tfh cells preferentially resided in the tertiary lymphoid structures, linking with cytotoxic CD8+ T cells and orchestrating a prolonged immune response against relapse18.